Author

Eveline Bruinstroop

National University of SingaporeORCID 0000-0001-6466-8497Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 1

Frequent Co-Authors

Brijesh Kumar SinghiD· 2 shared Madhulika Tripathi· 2 shared Paul M. YeniD· 2 shared Adrian D. PrinziD· 1 shared Anissa Anindya WidjajaiD· 1 shared Anita BoeleniD· 1 shared Ann-Kathrin Schörding· 1 shared Anne RabesiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Brijesh Kumar SinghORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PathologybioRxivPreprintOct 10, 2025

Extrahepatic effects of thyroid hormone and resmetirom override their beneficial hepatic effects in alcohol-associated liver disease in mice

Christoph Hoppe, Georg Sebastian Hönes, Adrian D. Prinz…·Lars Christian Moeller

The paper shows that thyroid hormone and resmetirom have harmful extrahepatic effects in white adipose tissue that counteract their beneficial effects on the liver in alcohol-associated liver disease in mice.

DOI 10.1101/2025.10.10.681680

mousebulk RNA-seq

𝕏 PostBluesky

Molecular BiologyMolecular MetabolismPeer-reviewedJun 5, 2021

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression

Eveline Bruinstroop, Jin Zhou, Madhulika Tripathi…·Paul M. Yen

62 citationstop 2%

mousebulk RNA-seq

𝕏 PostBluesky

Molecular BiologyGastroenterologyPeer-reviewedMay 9, 2019

IL-11 neutralising therapies target hepatic stellate cell-induced liver inflammation and fibrosis in NASH

Anissa Anindya Widjaja, Brijesh Kumar Singh, Eleonora Adami…·Stuart A. Cook

This study identifies IL-11 as a key driver of HSC-to-myofibroblast transformation in NASH, showing that targeting IL-11 reduces fibrosis and inflammation in preclinical models.

280 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky